Studies are configured in our Study Designer
Participants are recruited online or in investigation centers
Participants and investigators collect and securely share data for the study
Our blockchain enforces participant's consents providing a full audit trail
Evidence is generated in our proprietary HIVE platform
FDA receives the evidence on its HIVE instance for faster review
Standardized and regulatory-grade, de-identified data at patient level
Our users love our app's ease of use. Happy users = high adherence & perpetual data collection
Accelerate regulatory approvals for INDs and BLAs by months, lift FDA holds, save tens of millions of dollars of costs and accelerate revenue generation
JACQUELINE FRENCH, MD
CEO, Leading CRISPR Biotech in the U.S.
From patient recruitment to regulatory submission, the embleema platform collects, manages & analyzes all types of clinical & real-world data with full control from the user.
For the first time, there is a patient-first network that is changing the way people view, control, use and benefit from their data. Meet EDEN.Learn more